Literature DB >> 17938134

The polymorphism -863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout.

S-J Chang1, P-C Tsai, C-J Chen, H-M Lai, Y-C Ko.   

Abstract

OBJECTIVE: To investigate the associations between polymorphisms in the promoter of the tumour necrosis factor-alpha (TNF-alpha) gene and gout.
METHODS: The polymorphisms -308G/A and -863C/A in the TNF-alpha gene were determined in 106 gout patients and 159 healthy controls among male Taiwanese using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method. The biochemical markers, including Glutamic-oxaloacetic transaminase (GOT), Glutamic-pyruvic transaminase (GPT), uric acid, creatinine, total cholesterol (TC), triglycerides (TG), body mass index (BMI) and hypertension, as well as alcohol consumption were measured.
RESULTS: The gout patients had 9.43% (10/106) with genotype AA at polymorphism -863C/A showing a significantly higher fraction than controls (0.63%; 1/159, P < 0.001). The crude results also showed that the gout patients had significantly higher portions of abnormal GOT, GPT, creatinine, TC, TG, alcohol consumption, hypertension and hyperuricaemia than controls (P < 0.05), but the -308G/A, BMI and genotype CA at -863C/A did not show the same significant difference (P > 0.05). After adjustment by a stepwise logistic regression method, the hyperuricaemia, creatinine, GPT, TG and alcohol consumption as well as genotype AA at polymorphism -863C/A were found to be significantly associated with gout.
CONCLUSION: The genotype AA at polymorphism -863C/A in a recessive model showed a significant association with developing gout independent of hyperuricaemia, abnormal creatinine, higher TG, GPT and alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938134     DOI: 10.1093/rheumatology/kem235

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  The CC chemokine ligand 2 (CCL2) polymorphism -2518A/G is associated with gout in the Chinese Han male population.

Authors:  Ruixia Sun; Keke Zhang; Xiaokun Zhang; Lingling Cui; Can Wang; Qingsheng Mi; Shiguo Liu; Changgui Li
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

2.  What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases.

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 3.  Autoinflammatory Features in Gouty Arthritis.

Authors:  Paola Galozzi; Sara Bindoli; Andrea Doria; Francesca Oliviero; Paolo Sfriso
Journal:  J Clin Med       Date:  2021-04-26       Impact factor: 4.241

Review 4.  Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout.

Authors:  Weifeng Zhu; Yan Deng; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-07-24

Review 5.  The emerging role of biotechnological drugs in the treatment of gout.

Authors:  L Cavagna; W J Taylor
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

6.  Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.

Authors:  Ming-Chun Kuo; Shun-Jen Chang; Ming-Chia Hsieh
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study.

Authors:  Chung-Jen Chen; Chia-Chun Tseng; Jeng-Hsien Yen; Jan-Gowth Chang; Wen-Cheng Chou; Hou-Wei Chu; Shun-Jen Chang; Wei-Ting Liao
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.